FREE CASE EVALUATION: PLEASE CALL US AT 1-800-632-1404
Lipitor Lawsuit: Woman Claims Lipitor Fostering “National Epidemic” of Diabetes
Blockbuster cholesterol lowering drug Lipitor is fostering a “national epidemic” of Type 2 diabetes among women, claims a Lipitor diabetes lawsuit filed on August 15, 2013. California resident Aubrey Isom was diagnosed with diabetes within a year of using the drug to cut down her cholesterol and the risk of cardiovascular problems. According to her Lipitor diabetes lawsuit, manufacturer Pfizer was aware of diabetes risk linked to the anti-cholesterol drug, but did not inform the medical community or consumers. While Pfizer went to earn $125 billion, Isom now lives on restricted diet and has to take daily doses of diabetes drugs. She also faces an increased risk of heart disease, the warning that led her to take Lipitor.
The Lipitor diabetes lawsuit filed in a central California federal court is among the several litigations filed in the United States following the February 2012 FDA order for label changes on the drug to inform users of the increased diabetes risk.
Research on Lipitor Diabetes Risk
Well-documented research studies starting from 2004 have indicated an elevated risk of type 2 diabetes associated with Lipitor. Medical experts state that Lipitor should be used as the last resort for reducing cholesterol or where benefits outweigh the diabetes risk.
The Archives of Internal Medicine published a research report in January 2012 linking Lipitor to 50 percent higher risk of type 2 diabetes in postmenopausal women. The Women’s Health Initiative interviewed over 160,000 women above 50 years and less than 80 years. Researchers discovered that about 10 percent of those treated with Lipitor and similar statins developed type 2 diabetes. Almost half of those who did not use statins developed diabetes during the comparable time.
The Journal of the American Medical Association also came out with a study that explored links between Lipitor and onset of diabetes. Published in June 2011, the report was based on five different researches involving over 32,500 Lipitor-class statin drug users. The researchers in each of the five studies attested the fact that the higher the dose, the greater the diabetes risk. The findings followed a March 2011 report in the Journal of the American College of Cardiology that warned of 33 percent higher diabetes risk caused by Lipitor over a period of five years.
Scholars analyzed data collected from Australia, the Netherlands, the United States, and Pfizer’s own clinical trials to suggest association between Lipitor and type 2 diabetes. The risk increases with hypertension and excess weight. One of the studies indicated a higher risk of Lipitor-induced diabetes when compared with Zocor.
The Lancet journal reported a University of Glasgo research study in February 2010 that highlighted 13 different research reports involving over 90,000 women to conclude that Lipitor and statin drugs had an enhanced diabetes risk.
Lipitor Lawsuit
In February 2012, the FDA issued a formal warning linking Lipitor and other statins to the potential risk of type 2 diabetes. Issued 12 years after the introduction of the drug, it triggered filing of Lipitor lawsuits across the United States seeking product liability. One of the latest Lipitor lawsuits filed on September 13, 2013 in a Louisiana district court alleges that she developed diabetes in 2011 because of side effects of the anti-cholesterol drug that she used to take to ward off heart attack. She now faces an increased threat of cardiovascular problems due to diabetes.
A Mississippi woman has also made similar claims. Her Lipitor lawsuit filed in July 2012 claims that she had a healthy lifestyle until she was prescribed the cholesterol drug in 2009. The plaintiff gained weight and developed diabetes three years later. According to another Lipitor lawsuit filed in a Louisiana court, Dianne Christopher took the drug to cut down her low-density lipoprotein level to reduce cardiovascular disorder risk. However, she became diabetic because of Lipitor side effects and now faces an increased risk of heart problem.
About Us, Helping You
Our attorneys are currently reviewing any potential case involving someone that ingested Lipitor and have sustained a Lipitor injury and been diagnosed with Type 2 Diabetes. Our team of attorneys will review your potential case and provide a free case evaluation. We also handle Lipitor cases on a contingency fee, meaning there is no attorney’s fee unless we recover monies via a settlement or judgment. We also front all litigation expenses.
In order to try and help you, please contact us as soon as possible:
CALL: 1-800-632-1404
EMAIL: clicking here
FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.